Patents
1.
1/12/16 – Received US Patent US 9,233,119 B2 entitled:
USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS
Applicant – Miami University
Inventor – Michael A. Kennedy
2.
7/20/16 - Received US Divisional Patent 9,492,470 entitled:
USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS
Applicant – Miami University
Inventor – Michael A. Kennedy
3.
10/27/20 – Received US Patent US 10,813,957 B2
Engineered Oncolytic Viruses Containing Hyper-Binding Sites To Sequester And Suppress Activity Of Oncogenic Transcription Factors As A Novel Treatment For Human Cancer
Applicant – Miami University
Inventor – Michael A. Kennedy